» Articles » PMID: 28504110

Neurological Consequences of Obesity

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2017 May 16
PMID 28504110
Citations 206
Authors
Affiliations
Soon will be listed here.
Abstract

The high prevalence of obesity is associated with an enormous medical, social, and economic burden. The metabolic dysfunction, dyslipidaemia, and inflammation caused by obesity contribute to the development of a wide variety of disorders and effects on the nervous system. In the CNS, mild cognitive impairment can be attributed to obesity-induced alterations in hippocampal structure and function in some patients. Likewise, compromised hypothalamic function and subsequent defects in maintaining whole-body energy balance might be early events that contribute to weight gain and obesity development. In the peripheral nervous system, obesity-driven alterations in the autonomic nervous system prompt imbalances in sympathetic-parasympathetic activity, while alterations in the sensory-somatic nervous system underlie peripheral polyneuropathy, a common complication of diabetes. Pharmacotherapy and bariatric surgery are promising interventions for people with obesity that can improve neurological function. However, lifestyle interventions via dietary changes and exercise are the preferred approach to combat obesity and reduce its associated health risks.

Citing Articles

Soymilk yogurt prepared using TOKAI 759m ameliorates cognitive function through gut microbiota modulation in high-fat diet mice.

Nakashima Y, Hibi T, Urakami M, Hoshino M, Morii T, Sugawa H Curr Res Food Sci. 2025; 10:100993.

PMID: 40026903 PMC: 11869912. DOI: 10.1016/j.crfs.2025.100993.


Lipids dysregulation in diseases: core concepts, targets and treatment strategies.

Dakal T, Xiao F, Bhusal C, Sabapathy P, Segal R, Chen J Lipids Health Dis. 2025; 24(1):61.

PMID: 39984909 PMC: 11843775. DOI: 10.1186/s12944-024-02425-1.


The obesity pandemic and its impact on non-communicable disease burden.

Hildebrand S, Pfeifer A Pflugers Arch. 2025; .

PMID: 39924587 DOI: 10.1007/s00424-025-03066-8.


MiR-18a-LncRNA NONRATG-022419 pairs targeted PRG-1 regulates diabetic induced cognitive impairment by regulating NGF\BDNF-Trkb signaling pathway.

Xiang Q, Lin H, Tao J, Fu C, Liu L, Deng J Proteome Sci. 2025; 23(1):1.

PMID: 39915794 PMC: 11800523. DOI: 10.1186/s12953-025-00239-2.


Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration.

Zeng J, Cheong L, Lo C Front Endocrinol (Lausanne). 2025; 15:1456948.

PMID: 39897964 PMC: 11781992. DOI: 10.3389/fendo.2024.1456948.


References
1.
Lee C, Perkins B, Kayaniyil S, Harris S, Retnakaran R, Gerstein H . Peripheral Neuropathy and Nerve Dysfunction in Individuals at High Risk for Type 2 Diabetes: The PROMISE Cohort. Diabetes Care. 2015; 38(5):793-800. DOI: 10.2337/dc14-2585. View

2.
Stoeckel L, Arvanitakis Z, Gandy S, Small D, Kahn C, Pascual-Leone A . Complex mechanisms linking neurocognitive dysfunction to insulin resistance and other metabolic dysfunction. F1000Res. 2016; 5:353. PMC: 4897751. DOI: 10.12688/f1000research.8300.2. View

3.
van Vliet-Ostaptchouk J, Nuotio M, Slagter S, Doiron D, Fischer K, Foco L . The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord. 2014; 14:9. PMC: 3923238. DOI: 10.1186/1472-6823-14-9. View

4.
Vazquez L, Pazos F, Berrazueta J, Fernandez-Escalante C, Garcia-Unzueta M, Freijanes J . Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2004; 90(1):316-22. DOI: 10.1210/jc.2003-032059. View

5.
Papanas N, Vinik A, Ziegler D . Neuropathy in prediabetes: does the clock start ticking early?. Nat Rev Endocrinol. 2011; 7(11):682-90. DOI: 10.1038/nrendo.2011.113. View